New diabetes clinical trial: Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Published on: November 08, 2023 at 11:00PM
Conditions: Bioequivalence; Diabetes Mellitus, Type 2
Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
Sponsors: Galenicum Health
Completed
https://ift.tt/qOmlvK4